Académique Documents
Professionnel Documents
Culture Documents
From:
"Dan Primack"
Name:
Dan Primack
Email Address:
Dan_Primack@fortune.chtah.com
Subject:
Date:
22-09-2010 14:42:58
Message
Fortune Finance
Street Sweep
Term Sheet
Economics
Tech
Wall Street
Washington
Random Ramblings
Greetings from New York City, which today is tornado-free. No time to write a real column this morning - tons of news to compile, new
laptop to get used to - but here are two notes from the VC blogosphere:
*** Fred Wilson wrote a blog post last week about how the VC industry has bifurcated into two distinct spheres: IT and the rest of it. The
former gets all the buzz, and has experienced some fundamental changes (the rise of super-angels, the fall of startup costs, etc). The
latter is virtually ignored outside of select trade press, and today looks pretty much how it looked five, ten or twenty years ago.
He's right, of course. It's still virtually impossible to do lean life sciences, let alone lean pharma. Let me add a couple of thoughts to the
conversation:
Venture investment in IT not only has changed over time, but also has changed relative to life sciences investing. A decade ago, IT deals
dominated the VC landscape. According to MoneyTree, over 86% of all venture dollars invested went into technology companies (Internet,
software, hardware, chips, etc). If you only include Internet-specific and software deals, the figure still stands at nearly 62 percent (and
represents 65% of al companies funded).
So far in 2010, however, the situation has been reversed. Investments in IT deals now represent just 41% of all VC dollars disbursed, and
the more limited category stands at a paltry 31 percent. Life sciences investments, however, come in just a smidge higher. And if you were
to include something like cleantech in the "other" sample, the disparity begins to grow.
IT continues to lead in terms of "most companies funded," but the gap is narrowing. Obsessing over the valuations/exit prospects of
companies like FourSquare or Twitter is great fun (and great for pageviews), but the real money is being made or lost elsewhere.
file:///C:/Users/srinivas/AppData/Local/Temp/tmp.tmp
16-12-2015
Page 2 of 5
*** Speaking of misplaced attention, the VC world is abuzz this morning with Mike Arrington's report of a "secret meeting" of superangels in San Francisco. He alleges collusion against both entrepreneurs and traditional VCs.
One of the meeting participants, Dave McClure, has already written a screed against Arrington's report, and I don't have enough inside
knowledge to take sides. However
There seems to be an inherent contradiction in Arrington's story: If super-angels are planning to price-fix, wouldn't that enable the very
"traditional" VCs that they are purporting to thwart? If McClure, et. all begin offering below-market terms, wouldn't the large checkbooks be
emboldened?
Moreover, the very reason that so many individual angels became super-angels was to reduce the need for deal syndication. This would
seem to encourage it, since meeting participants would need to work together in order to preempt the aforementioned competition.
Finally, I rarely believe in collusion reports. Sure it sometimes happens (see Gedman, Rich), but usually it's a lot of hot air (see buyouts,
big). That said, I'm interested in your thoughts
Pre-marketing, including Facebook revenge, seed-stage collusion, corporate defaults decrease, Mark Cuban's insider trading case
is revived and LPs sue a buyout firm for using it as "a personal piggy-bank."
Secrets of the Undercover Bosses
Madison Avenue warms to electric cars
The disconnect between productivity and hiring
The Fed promises more inflation
VC Deals
Boston Heart Lab, a Framingham, Mass.-based provider of specialized diagnostics for patients with heart disease, has raised $10 million
in Series C funding. Bain Capital Ventures led the round. The company also announced that Susan Hertzberg has joined as CEO. She
previously ran the North American unit of France's Ipsogen SA. www.bostonheartlab.com
Rocket Fuel Inc., a Redwood City, Calif.-based provider of online ad optimization solutions, has raised $10 million in Series B funding.
Nokia Growth Partners led the round, and was joined by Northgate Capital and return backers Mohr Davidow Ventures and Labrador
Ventures. www.rocketfuel.com
Private Outlet, a French operator of an online private sale site for brand-name clothing and accessories, has raised 9 million in secondround funding. GIMV and Turenne Capital co-led the round, and were joined by return backers BayTech Venture Capital, Kreos Capital
and GP Bullhound. www.privateoutlet.com
Arterial Remodeling Technologies, a French developer of bioresorbable coronary polymer stents, has raised $8.5 million in new VC
funding. InnoBio Fund was joined by return backers Matignon Technologies and Amundi Private Equity Funds. The company has now
file:///C:/Users/srinivas/AppData/Local/Temp/tmp.tmp
16-12-2015
Page 3 of 5
IPOs
Betfair, a UK-based online gaming exchange, is planning to raise around 1.5 billion via an IPO in London. Shareholders include
Softbank and Balderton Capital.
Restoration Hardware, a hardware retailer taken private two years ago by Catterton Partners, is planning to raise up to $300 million in an
IPO, according to Reuters.
file:///C:/Users/srinivas/AppData/Local/Temp/tmp.tmp
16-12-2015
Page 4 of 5
Exits
3i Group has sold its 6.6% stake in Welspun Corp., a listed Indian steel pipe-maker, according to the Economic Times. No additional
information was disclosed. www.3i.com
AXA Private Equity has agreed to sell its majority stake in global chemical company Eliokem to Omnova Solutions (NYSE: OMN), for
227.5 million. www.axaprivateequity.com
PAI Partners is planning to sell its majority stake in Italian department store chain Gruppo Coin, according to Reuters. The auction is
expected to launch before year-end, and could be valued at around 1.5 billion. www.paipartners.com
TPG Capital is planning to sell its 9.3% stake in Malaysia-based Parkway Life REIT (SI: PWLR), according to IFR Asia. The deal could
be worth nearly $70 million.
Other Deals
Sinochem Corp. reportedly has hired Deutsche Bank and Citigroup to advise it on how to rival BHP Biliton's $39 billion bid for Potash
Corp.
VideoEgg Inc., a San Francisco-based provider of Web-based video publishing, has agreed to acquire Six Apart, a San Francisco-based
provider of blogging software and services. No financial terms were disclosed for the deal, which will result in a single company named
SAY Media. VideoEgg has raised around $40 million in VC funding, from from August Capital, First Round Capital and Maveron. Six Apart
has raised around $22 million in VC funding from August Capital, Focus Ventures and Intel Capital. www.videoegg.com
Bonanzle Inc. has acquired the assets of 1000 Markets Inc., to expand its online marketplace for artisan goods, coins and other items. It
also has changed its name to Bonanza. No financial terms were disclosed. Bonanzle had raised a small amount of VC funding from firms
like Ignition Partners, Matrix Partners, Voyager Capital and Founder's Co-op, while 1000 Markets was backed by Founders Fund and True
Ventures. www.bonanzle.com
Busted
Thompson Publishing Holding Co., a Washington, D.C.-based professional publisher for business and government executives, has filed
for Chapter 11 bankruptcy protection. The company also entered into an agreement with stalking-horse bidder PNC Bank, which has
agreed to provide debtor-in-possession financing. Avista Capital Partners is the company's majority shareholder. www.thompson.com
file:///C:/Users/srinivas/AppData/Local/Temp/tmp.tmp
16-12-2015
Page 5 of 5
Email Administrator
One CNN Center
Atlanta, Georgia 30303
This message has been sent to you because you are currently subscribed to The Term Sheet.
To unsubscribe, click here
PRIVACY POLICY
Please read our Privacy Policy, or copy and paste this link into your browser:
http://money.cnn.com/services/privacy/
file:///C:/Users/srinivas/AppData/Local/Temp/tmp.tmp
16-12-2015